What is UnixMed?
UnixMed Inc. operates as a specialized manufacturer and provider of advanced oxygen analysis and delivery solutions. The company maintains a diverse product portfolio that includes high-precision pulse oximeters, neonatal care equipment, air-oxygen mixers, and sophisticated ventilator systems. Serving a broad spectrum of clients ranging from acute care hospital environments to homecare providers and specialized industrial sectors like scuba, UnixMed has established itself as a vital link in the healthcare supply chain. Their commitment to clinical safety and technical reliability became particularly pronounced during the global pandemic, where their respiratory support technologies played a pivotal role in patient care and recovery efforts.
How much funding has UnixMed raised?
UnixMed has raised a total of $12K across 1 funding round:
Debt
$12K
Debt (2021): $12K with participation from PPP
Key Investors in UnixMed
PPP
Public-Private Partnership
What's next for UnixMed?
With the recent influx of capital, UnixMed is strategically positioned to transition from its current Series A/B growth stage toward broader market penetration. The company is expected to prioritize the scaling of its manufacturing infrastructure and the enhancement of its technical support services to meet rising global demand for respiratory diagnostics. Future initiatives will likely focus on R&D investments to refine existing ventilator technologies and expand the company's reach into emerging healthcare markets, ensuring that their clinical equipment remains at the forefront of medical innovation and patient safety standards.
See full UnixMed company page
